SCHEMBL4388703

SCHEMBL4388703

COC(=O)Cc1ccccc1Sc1c[nH]c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.50
GFER P55789 2/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.47
IDO1 P14902 1/20 0.47
ALOX5 P09917 1/20 0.46
EGFR P00533 2/20 0.46
STAT3 P40763 2/20 0.46
NR4A2 P43354 1/20 0.46
CREBBP Q92793 1/20 0.46
TUBB4A P04350 2/20 0.46
TUBB P07437 2/20 0.46
TUBA3C P0DPH7 2/20 0.46
TUBA1B P68363 2/20 0.46
TUBA4A P68366 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386307 0.84 TUBB4A (0.54) GFERMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL4386796 0.83 STAT3 (0.59) GFERMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL30832961 0.83 STAT3 (0.59) GFERMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL4388147 0.82 GFER (0.49) PKMGFERMAPTSMN1; SMN2MEN1
SCHEMBL584367 0.81 PKM (0.73) PKMMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL29466101 0.81 PKM (0.73) PKMMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL27710581 0.80 MAPT (0.53) PKMGFERMAPTSMN1; SMN2MEN1
SCHEMBL9999239 0.77 STAT3 (0.67) GFERMAPTPOLBALOX5STAT3
SCHEMBL1399362 0.77 IFNAR1 (0.60) GFERMAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL737610 0.75 GFER (0.64) GFERMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893575-B1 2-(1H-INDOLYLSULFANYL)-ARYL AMINE DERIVATIVES H LUNDBECK AS (DK) 2017-01-11 EP disclosed
US-7629473-B2 2-(1H-indolylsulfanyl)-aryl amine derivatives H. LUNDBECK A/S (DK) 2009-12-08 US disclosed
EP-1893575-A2 2-(1H-INDOLYLSULFANYL)-ARYL AMINE DERIVATIVES H.Lundbeck A/S (DK) 2008-03-05 EP disclosed
WO-2006134499-A2 2-(1H-INDOLYLSULFANYL)-ARYL AMINE DERIVATIVES H. LUNDBECK A/S (DK) 2006-12-21 WO disclosed
US-20060287382-A1 2-(1H-indolylsulfanyl)-aryl amine derivatives H. LUNDBECK A/S (DK) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287382-A1 2-(1H-indolylsulfanyl)-aryl amine derivatives CYP11B2, CYP1A2, CYP4B1 PKM 2826/4885GFER 4340/4885MAPT 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.